2019 annual financial data
Seres Therapeutics 2019 Operating margin
Seres Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -208.31%.
Operating income was -71,876,000 USD and net income was -70,279,000 USD.
Operating cash flow was -76,520,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34,505,000 USD
- Operating income
- -71,876,000 USD
- Net income
- -70,279,000 USD
- Operating cash flow
- -76,520,000 USD